News

Researchers have developed a modular immune organoid that can replicate the anatomical structures found within lymph nodes.

As a tumor grows, the environment surrounding the cancer stiffens, as does the tumor itself. And there is another effect of that stiffening: damage to the blood vessels of the tumor.

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011.

An internal code in cellular molecules called messenger RNA predetermines how much protein they will produce.

A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence.

The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy.

Investigators at Weill Cornell Medicine and the Meinig School of Biomedical Engineering at Cornell University are exploring how genes that lead to resistance to antibiotics proliferate in the gut.

An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice.

A severely brain injured woman, who recovered the ability to communicate using her left eye, restored connections and function of the areas of her brain responsible for producing expressive language and responding to human speech, according to new research from Weill Cornell Medicine scientists.

Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.

High blood pressure transforms cells of the immune system that reside around cerebral blood vessels and normally protect the brain into agents of cognitive decline.

Seven winners have been selected for the third round of the Daedalus Fund for Innovation awards, an innovative Weill Cornell Medicine program that helps advance promising applied and translational research projects and emerging technologies that have commercial potential. 

Weill Cornell Medicine (WCM) and the New York Genome Center (NYGC) were...

A new study has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen testing. 

Individual proteins coalesce to create an intricate network. When intact, that network protects certain cancers...

Benefactors Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.

Study provides a framework for understanding the biological basis for chemotherapy resistance in bladder cancer.

An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease.

Led by researchers from NewYork-Presbyterian and Weill Cornell Medicine, the new study published in the annals of surgical oncology finds that cryoablation is a viable treatment for some breast cancers

The addition of a chemical tag on an RNA molecule is the critical switch that inactivates one X chromosome in every cell, ensuring healthy development in all female mammals.